RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study

Completed · Not applicable

Conditions studied: Aphakia, Cataract

In brief

The primary objective of this study is to conduct a post-approval study which compares the LAL to a monofocal control IOL for safety outcomes.

Key facts

Study ID
NCT05202808
Run by
RxSight, Inc.
People needed
500
Starts
2021-12-03
Expected to finish
2024-12-16
Last updated by the study team
2025-04-20

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.